Critical Outcome Technologies and Delmar Chemicals Sign Collaboration Agreement

News   Sep 12, 2012

 
Critical Outcome Technologies and Delmar Chemicals Sign Collaboration Agreement
 
 
 

RELATED ARTICLES

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

New Drug Class: Potential Therapeutics for Alzheimer’s Disease?

News

One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.

READ MORE

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News

Scientists performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE